Stockreport

GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026 [Yahoo! Finance]

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for Cancer Research (AACR) Annual Me [Read more]